NCT05961540

Brief Summary

This study is a randomized block trial designed to evaluate the effectiveness of a breastfeeding behavioural intervention program for mothers of infants with congenital heart disease (CHD). The purpose of this study is to compare exclusive breastfeeding rates, changes in weight-for-age z-scores (ΔWAZ) and height-for-age z-scores (ΔHAZ), and maternal breastfeeding behaviour between the intervention group and the control group at 1, 3, and 6 months of age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 7, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

June 7, 2023

Last Update Submit

July 15, 2024

Conditions

Keywords

Heart Defects, CongenitalBreast FeedingInfant, NewbornFeeding intervention

Outcome Measures

Primary Outcomes (3)

  • Exclusive breastfeeding rate

    The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.

    At the age of 1month

  • Exclusive breastfeeding rate

    The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.

    At the age of 3 months

  • Exclusive breastfeeding rate

    The exclusive breastfeeding rate equals (the number of CHD infants who choose exclusive breastfeeding) divided by (the total number of CHD infants) multiplied by 100%.

    At the age of 6 months

Secondary Outcomes (7)

  • Breastfeeding Behavior Questionnaire for Mothers of Infants with CHD

    At baseline and at 6 months of age.

  • ΔWAZ at 1 month of age compared to birth, separated into two groups.

    At the age of 1month

  • ΔWAZ at 3 months of age compared to birth, separated into two groups.

    At the age of 3 months

  • ΔWAZ at 6 months of age compared to birth, separated into two groups.

    At the age of 6 months

  • ΔHAZ at 1 month of age compared to birth, separated into two groups.

    At the age of 1 month

  • +2 more secondary outcomes

Study Arms (2)

Conventional care group

OTHER

The management of infants with CHD and their mothers is based on the current breastfeeding process and care protocols at the Cardiovascular Centre of the Children's Hospital of Fudan University.

Other: Conventional care

Breastfeeding intervention program

EXPERIMENTAL

Implement intervention programs to improve breastfeeding behaviour among mothers of infants with CHD and observe ongoing changes.

Behavioral: Breastfeeding behavioural intervention for mothers of infants with CHD

Interventions

1. Instruct parents to follow up with the baby at the doctor's appointment. 2. Provide telephone follow-up visits at 1 month, 3 months, and 6 months of age to assess the baby's feeding and physical development (height and weight).

Conventional care group

Based on the Behavioural Change Wheel theory,the intervention program is developed and implemented to promote the change in breastfeeding behavior of mothers with CHD infants,so as to improve the exclusive breastfeeding rate of this population.Specific programs include: 1. Evaluate signs of hunger and satiety in infants. 2. Family visits, face-to-face guidance on breastfeeding skills, breast milk storage and management. 3. Training methods for promoting breast milk secretion. 4. To explain common feeding difficulties manifestations and treatment methods in infants with CHD. 5. Establish a breastfeeding promotion alliance. 6. Teach mothers to weigh their babies before and after breastfeeding to determine breast milk intake. 7. Assess and guide the growth and development of infants with CHD.

Breastfeeding intervention program

Eligibility Criteria

Age1 Day - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • For infants
  • CHD was diagnosed within 14 days of birth.
  • From birth to 14 days old.
  • Exclusive breastfeeding or mixed feeding during enrollment.
  • For mothers
  • The mother is the primary caretaker for the infant with CHD.
  • The mother has a smartphone and has the skills to use it.
  • She has good reading and communication skills and can work fully with others.
  • In good physical health with no clear disability, such as severe cardiovascular disease, etc.
  • In good mental health, without any clearly diagnosed anxiety disorders, depression, etc.
  • Mothers must be at least 18 years old.

You may not qualify if:

  • For infants
  • Congenital anomalies such as gastrointestinal anomalies, facial anomalies, cleft lip and palate, and various syndromes due to chromosomal abnormalities are combined.
  • Cardiac surgery was performed within 14 days of birth.
  • The infant is not breastfed according to medical standards (for example, with galactosemia, phenylketonuria, or maple glycosuria).
  • For mothers
  • Mothers with mental illness, cognitive impairment, etc. who struggle to communicate effectively.
  • Those who have contraindications to breastfeeding, such as long-term use of specific types of drugs such as chemotherapy drugs, opioids, anti-epileptic drugs, anti-depressants, psychotropic drugs, etc.
  • Systemic infectious diseases during feeding include HIV positive, active or untreated tuberculosis, recent syphilis infection, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

Location

MeSH Terms

Conditions

Heart Defects, CongenitalBreast Feeding

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFeeding BehaviorBehavior

Study Officials

  • Ying Gu, Doctor

    Children's Hospital of Fudan University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2023

First Posted

July 27, 2023

Study Start

April 25, 2023

Primary Completion

March 1, 2024

Study Completion

May 30, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Locations